Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
e decrease » we decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
_ largest » _ large (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
e decrease » we decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
_ largest » _ large (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).
Published 2024“…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
-
7
-
8
-
9
-
10
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
Published 2025“…When they stop being introduced in further assembly events (i.e. introduced species do not carry any mutualistic interactions), their proportion slowly decreases with successive invasions. …”
-
11
-
12
-
13
Dox-inducible expression of HA-MAD1 in colon is sufficient to decrease p53 expression and cause chromosome missegregation.
Published 2024“…Lanes 2 and 3 are from different mice of the same genotype. (E) Quantification (mean +/- SEM) of p53 protein levels, based on immunoblotting with the 1C12 antibody. …”
-
14
-
15
-
16
Baseline patient characteristics across neutralizing monoclonal antibody trials.
Published 2025Subjects: -
17
-
18
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
Published 2025Subjects: -
19
-
20
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
Published 2025Subjects: